855-226-9991 [email protected]

News

Cardio Diagnostics Jan 2021 Press Release

Cardio Diagnostics Jan 2021 Press Release

Cardio Diagnostics’ Epi+Gen CHD at-home sampling kit: Potential patients fill out a screening questionnaire that is reviewed by a board-certified clinician. If eligible for the test, a sampling kit is sent to their home. After the sample is collected, it is shipped...

Cardio Diagnostics receives a Phase I NIH SBIR

Cardio Diagnostics receives a Phase I NIH SBIR

Cardio Diagnostics received $225K in National Institutes of Health (NIH) funding to further develop our integrated genetic-epigenetic coronary heart disease risk screening technology.

Coronary Heart Disease Risk Prediction Paper Published

Coronary Heart Disease Risk Prediction Paper Published

Cardio Diagnostics’ simple DNA test is better at identifying those at risk for coronary heart disease than standard approaches. This manuscript details the performance of our technology and highlights its ability to more sensitively (by >30%) identify those at risk...